Straight answers about research peptides.
Comparisons, quality questions, and the practical details people actually search for — each one cited to the primary literature and written for laboratory research context.
- Comparisons
BPC-157 vs TB-500 — what the tendon literature actually compared
Two repair-research peptides with different mechanisms, different evidence bases, and almost no head-to-head data. What each was actually studied for, and where the comparison breaks down.
7 min - Comparisons
Ipamorelin vs Sermorelin — two different receptors, often confused
They are grouped together as growth-hormone research peptides, but they act on different receptors. What that distinction means, and why selectivity is the point of the comparison.
6 min - Comparisons
Selank vs Semax — two Russian-developed peptides, two different origins
Frequently sold as a pair and often assumed to be variants of one another. They derive from completely different parent molecules, and the research literature reflects that.
6 min - Comparisons
Sermorelin vs Tesamorelin — same receptor, very different regulatory status
Both are GHRH analogues acting at the same receptor. One is an approved prescription drug and the other is not, and that difference matters more than any mechanism debate.
6 min - Comparisons
BPC-157 vs KPV — two gut-model peptides from completely different origins
Both appear in gastrointestinal research, which is where the similarity ends. One is a gastric-protein fragment, the other a three-amino-acid tail of a hormone.
6 min - Comparisons
MOTS-c vs NAD+ — one is a peptide and the other is not
Compared as if they were two options in one category. One is a mitochondrial-derived peptide; the other is a coenzyme in every cell. That error explains the confusion.
6 min - Comparisons
Epitalon vs Pinealon — two short bioregulators with a shared research lineage
Both are very short peptides from the same Russian research tradition, and both carry the same evidence caveat. What each one actually is, and why the literature is hard to weigh.
5 min - Comparisons
Dihexa vs Semax — different molecules, both wearing the nootropic label
Grouped by the marketing category rather than by chemistry. One is an angiotensin-IV-derived compound, the other an ACTH fragment analogue, and their evidence bases barely overlap.
5 min - Comparisons
CJC-1295, Ipamorelin, Sermorelin, Tesamorelin — the four compared
Four compounds, two mechanisms, one approved drug among them. A single table for the comparison people usually assemble from four separate pages.
7 min - Comparisons
CJC-1295 vs Tesamorelin — two GHRH analogues, one of them a drug
Both mimic the same releasing hormone at the same receptor. They differ in how they were modified and, decisively, in regulatory standing.
5 min - Comparisons
GHK-Cu vs NAD+ — a copper tripeptide and a coenzyme
Another pairing that only exists because both sit on the same shelf. One is a three-amino-acid copper complex; the other is not a peptide at all.
5 min - Comparisons
Epitalon vs DSIP — both associated with sleep research, for different reasons
One is a four-amino-acid bioregulator from the Russian pineal programme; the other a nonapeptide named for the effect it was isolated in connection with.
5 min - Comparisons
BPC-157 vs CJC-1295 — a repair peptide and a releasing-hormone analogue
Compared often, related barely at all. One is studied in tissue-repair models, the other mimics a hypothalamic releasing hormone.
5 min - Comparisons
5-Amino-1MQ vs MOTS-c — two metabolic research compounds, different targets
Both appear in metabolic research and only one is a peptide. What each is studied against, and why the pairing is a shelf rather than a category.
5 min - Comparisons
MOTS-c vs Tesamorelin — a mitochondrial peptide and a releasing-hormone analogue
One is encoded in mitochondrial DNA; the other mimics a hypothalamic hormone and is an approved drug. Different pathways, different regulatory worlds.
5 min - Comparisons
NAD+ vs Sermorelin — a coenzyme and a releasing-hormone analogue
Paired in anti-ageing searches and otherwise unrelated. One is not a peptide; the other acts on an endocrine axis.
4 min - Comparisons
Pinealon vs Semax — both Russian-developed, very different evidence bases
A three-amino-acid bioregulator against an ACTH-fragment analogue. Shared development country, unrelated molecules, and one has a far larger literature.
5 min - Comparisons
Dihexa vs Pinealon — Western academic work against a Russian bioregulator
Grouped under the cognitive label and produced by entirely separate research worlds. The interesting difference is how each body of evidence is constituted.
5 min
Browse by category
- Comparisons
- Two compounds, side by side, on what the literature actually measured.
- Getting started
- Plain answers to the questions people ask before their first order.
- Quality & testing
- Purity, chromatograms, certificates — how to read what you are sold.
- Storage & handling
- Reconstitution, temperature, shelf life, and the arithmetic behind them.
- Choosing a supplier
- What separates a documented supplier from a drop-shipper.